Literature DB >> 26590778

Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification.

Robert A deKemp1, Jennifer M Renaud2, Ran Klein3, Rob S B Beanlands2.   

Abstract

Myocardial perfusion imaging is performed most commonly using Tc-99m-sestamibi or tetrofosmin SPECT as well as Rb-82-rubidium or N-13-ammonia PET. Diseased-to-normal tissue contrast is determined by the tracer retention fraction, which decreases nonlinearly with flow. Reduced tissue perfusion results in reduced tracer retention, but the severity of perfusion defects is typically underestimated by 20% to 40%. Compared to SPECT, retention of the PET tracers is more linearly related to flow, and therefore, the perfusion defects are measured more accurately using N-13-ammonia or Rb-82.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coronary flow reserve; Myocardial blood flow; Myocardial perfusion imaging

Mesh:

Substances:

Year:  2015        PMID: 26590778     DOI: 10.1016/j.ccl.2015.08.001

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  3 in total

Review 1.  PET/MR: Yet another Tesla?

Authors:  Markus Schwaiger; Karl Kunze; Christoph Rischpler; Stephan G Nekolla
Journal:  J Nucl Cardiol       Date:  2016-09-22       Impact factor: 5.952

2.  Prediction of long-term (> 10 year) cardiovascular outcomes in heart transplant recipients: Value of stress technetium-99m tetrofosmin myocardial perfusion imaging.

Authors:  Jesse F Veenis; Hendrik J Boiten; Jan C van den Berge; Kadir Caliskan; Alex P W M Maat; Roelf Valkema; Alina A Constantinescu; Olivier C Manintveld; Felix Zijlstra; Ron T van Domburg; Arend F L Schinkel
Journal:  J Nucl Cardiol       Date:  2017-11-07       Impact factor: 5.952

Review 3.  The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease.

Authors:  Chuanbin Liu; Dong Han; Ping Liang; Yang Li; Feng Cao
Journal:  Front Cell Dev Biol       Date:  2021-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.